MetaCap

Verrica Pharmaceuticals Statistics

NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.74-0.145 (-5.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Verrica Pharmaceuticals by the numbers

Verrica Pharmaceuticals has a market capitalization of $47.1 million based on 17.18M shares outstanding. With trailing EPS of $-2.30, Verrica Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.8% below its 50-day average and 48.3% below its 200-day average.

Average daily trading volume is 68.78K shares, or about $188,468 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VRCA valuation vs. peer median

VRCA compared with the median of 8 peer companies
MetricVRCAPeer medianDifference
Market cap$47.07M$46.70M+1%
Avg. volume68.78K957.84K-93%

Peer median across 8 companies: NMAD, ONCY, TNXP, MIST, RFL, HRTX, HOWL, RNXT.

Valuation

Market cap
$47.07M
Price / sales (latest FY)
1.32
EPS (TTM)
$-2.30

Price and trading

Previous close
2.89
Open
2.88
Day range
2.73 – 2.96
52-week range
2.73 – 9.82
52-week change
-34.92%
Beta
—
Volume
127.03K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
47.07M
Forward Pe
-1.79
Eps
-2.30
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
9.82
Week52 Low
2.73
Avg Volume
68,784.00
Shares Outstanding
17.18M
Ma50
3.85
Ma200
5.30
Earnings Date
Nov 12, 2026
Pct From52w High
-72.10%
Pct From52w Low
0.37%

Related